DE3881254D1 - Pharmazeutische zusammensetzung. - Google Patents

Pharmazeutische zusammensetzung.

Info

Publication number
DE3881254D1
DE3881254D1 DE8888302772T DE3881254T DE3881254D1 DE 3881254 D1 DE3881254 D1 DE 3881254D1 DE 8888302772 T DE8888302772 T DE 8888302772T DE 3881254 T DE3881254 T DE 3881254T DE 3881254 D1 DE3881254 D1 DE 3881254D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
composition
pharmaceuticals
utilizes
nasal administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888302772T
Other languages
English (en)
Other versions
DE3881254T2 (de
Inventor
Hanna R Kowarski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple University of Commonwealth System of Higher Education
Original Assignee
Temple University of Commonwealth System of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple University of Commonwealth System of Higher Education filed Critical Temple University of Commonwealth System of Higher Education
Publication of DE3881254D1 publication Critical patent/DE3881254D1/de
Application granted granted Critical
Publication of DE3881254T2 publication Critical patent/DE3881254T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8888302772T 1987-04-01 1988-03-29 Pharmazeutische zusammensetzung. Expired - Fee Related DE3881254T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3332587A 1987-04-01 1987-04-01

Publications (2)

Publication Number Publication Date
DE3881254D1 true DE3881254D1 (de) 1993-07-01
DE3881254T2 DE3881254T2 (de) 1993-09-02

Family

ID=21869753

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888302772T Expired - Fee Related DE3881254T2 (de) 1987-04-01 1988-03-29 Pharmazeutische zusammensetzung.

Country Status (5)

Country Link
EP (1) EP0285367B1 (de)
JP (1) JPH0717520B2 (de)
AT (1) ATE89744T1 (de)
CA (1) CA1335076C (de)
DE (1) DE3881254T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223132B (it) * 1987-11-13 1990-09-12 Isf Spa Composizione farmaceutica per somministrazione nasale
GB2212062B (en) * 1987-11-13 1991-07-17 Isf Spa Pharmaceutical compositions containing a calcitonin and a glycyrrhizinate ab- sorption enhancer
AU639228B2 (en) * 1989-02-17 1993-07-22 Transave, Inc. Lipid excipient for nasal delivery and topical application
IT8920486A0 (it) * 1989-05-12 1989-05-12 Isf Spa Composizioni farmaceutiche.
IT1254321B (it) * 1992-04-10 1995-09-14 Kemiprogress S R L Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
WO1995011042A1 (fr) * 1993-10-21 1995-04-27 Hisamitsu Pharmaceutical Co., Inc. Composition administree par voie nasale et preparation contenant celle-ci

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
JPS5927978A (ja) * 1982-08-09 1984-02-14 Terumo Corp インドメタシン入り粘着テ−プ
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration

Also Published As

Publication number Publication date
ATE89744T1 (de) 1993-06-15
CA1335076C (en) 1995-04-04
DE3881254T2 (de) 1993-09-02
EP0285367B1 (de) 1993-05-26
JPS63258821A (ja) 1988-10-26
JPH0717520B2 (ja) 1995-03-01
EP0285367A3 (en) 1990-03-14
EP0285367A2 (de) 1988-10-05

Similar Documents

Publication Publication Date Title
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
PT88962A (pt) Aparelho aperfeicoado de libertacao transdermica de medicamentos
IE862404L (en) Hydroxamic acid derivatives
FI905718A (fi) Transdermalt medel.
ATE81009T1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
DK414389D0 (da) Farmaceutisk praeparat indeholdende et aminosyrederivat med renin-inhibitorisk virkning
FI935728A (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
AU1819288A (en) Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
ATE94765T1 (de) Pharmazeutische praeparate zur verbesserten resorption antibakterieller verbindungen.
DE3881254D1 (de) Pharmazeutische zusammensetzung.
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
IE872667L (en) Pharmaceutical compositions
ATE59550T1 (de) Chlorpheniramine therapie.
AU2908389A (en) Device for administering medicaments by atomization in intubated or tracheotomized patients
DK298389A (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
IT1198238B (it) Composti ad attivita' antibiotica
MY101821A (en) Quinazolinediones and pyridopyrimidinediones
ATE89163T1 (de) Topisch anzuwendende diclofenac enthaltende arzneizubereitungen.
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
DE3689254D1 (de) Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation.
DK192487A (da) Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning
EP0410652A3 (en) Improvement of excretion of potassium ion by prostanoic acid derivatives
ES8705888A1 (es) Procedimiento para preparar compuetos de imidazo-isoquino-leina y de imidazo-tienopiridina
SU1744810A1 (ru) Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон"
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee